60 DEGREES PHARMACEUTICALS, INC.
SXTPWN/A
NASDAQBiotechnology🇺🇸North America
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Feb 15, 2027
48wMarket Overview
Stock performance and key metrics
SXTPW News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
Tafenoquine
Babesiosis
Tafenoquine 100mg
Chronic Babesiosis
Tafenoquine Oral Tablet
COVID 19 Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tafenoquine | Phase 2 | Babesiosis | - | - |
Tafenoquine 100mg | Phase 2 | Chronic Babesiosis | - | - |
Tafenoquine Oral Tablet | Phase 2 | COVID 19 Disease | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply